SILICON LABORATORIES INC. Earnings Per Share Disclosure
| Year Ended | |||||||||||||||||
| January 3, 2026 | December 28, 2024 | December 30, 2023 | |||||||||||||||
| Net loss | $ | (64,907) | $ | (191,010) | $ | (34,516) | |||||||||||
| Shares used in computing basic loss per share | 32,721 | 32,191 | 31,804 | ||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||
| Stock-based awards and convertible debt | — | — | — | ||||||||||||||
| Shares used in computing diluted loss per share | 32,721 | 32,191 | 31,804 | ||||||||||||||
| Loss per share: | |||||||||||||||||
| Basic | $ | (1.98) | $ | (5.93) | $ | (1.09) | |||||||||||
| Diluted | $ | (1.98) | $ | (5.93) | $ | (1.09) | |||||||||||
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.